Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2002 May;53(5):469-73.
doi: 10.1046/j.1365-2125.2002.01575.x.

Metformin does not enhance ovulation induction in clomiphene resistant polycystic ovary syndrome in clinical practice

N D C Sturrock  1 , B Lannon, T N Fay
Affiliations
Clinical Trial

Metformin does not enhance ovulation induction in clomiphene resistant polycystic ovary syndrome in clinical practice

N D C Sturrock et al. Br J Clin Pharmacol. 2002 May.

Abstract

Aims: To determine whether metformin pretreatment has beneficial effects in clomiphene resistant infertile women with polycystic ovary syndrome (PCOS) in an infertility clinic.

Methods: This was a randomized placebo controlled double-blind crossover study of 3 months metformin (1500 mg day-1)/placebo, followed by 3 months metformin/placebo together with clomiphene (50-100 mg for 5 days) for three cycles in clomiphene resistant women with PCOS. The primary outcomes were restoration of spontaneous menses, ovulation induction (spontaneous or clomiphene induced) and pregnancy. Secondary endpoints were changes in biochemical parameters related to androgens and insulin.

Results: Twelve women completed the metformin arm and 14 the placebo arm. Spontaneous menstruation resumed in five metformin treated patients and in six placebo treated women, P=0.63. No women given metformin spontaneously ovulated, although one patient given placebo did, P=0.30. There was no difference in the efficacy of clomiphene between the two groups with ovulation being induced in five (out of 12) metformin treated women and four (out of 14) placebo treated women, P=0.63. Pregnancy occurred in three (out of 12) women given metformin and two (out of 14) women given placebo, P=0.59.

Conclusions: Metformin is not always beneficial when given to clomiphene resistant infertile women with PCOS in clinical practice.

PubMed Disclaimer

Figures

Figure 1
Figure 1
The study design.
See this image and copyright information in PMC

References

    1. Barbieri RL, Makris A, Randall RW, Daniels G, Kistner RW, Ryan KJ. Insulin stimulates androgen accumulation in incubations of ovarian stroma obtained from women with hyperandrogenism. J Clin Endocrinol Metab. 1986;62:904–910. - PubMed
    1. Ehrmann DA, Rosenfield RL, Barnes RB, Brigell DF, Sheikh Z. Detection of functional ovarian hyperandrogenism in women with androgen excess. N Engl J Med. 1992;327:157–162. - PubMed
    1. Velazquez EM, Mendoza S, Hamer T, Sosa F, Glueck CJ. Metformin therapy in polycystic ovary syndrome reduces hyperinsulinaemia, insulin resistance, hyperandrogenemia, and systolic blood pressure, while facilitating normal menses and pregnancy. Metabolism: Clin Exp. 1994;43:647–654. - PubMed
    1. Dunaif A, Scott D, Finegood D, Quintana B, Whitcomb R. The insulin sensitising agent troglitazone improves metabolic and reproductive abnormalities in the polycystic ovarian syndrome. J Clin Endocrinol Metab. 1996;81:3299–3306. - PubMed
    1. Davidson MB, Peter AL. An overview of metformin in the treatment of type 2 diabetes mellitus. Am J Med. 1997;102:99–110. - PubMed